Topic Hub
10 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 10 of 10 clinical reviews.
Specific dietary, hydration, meal-timing, and supplement strategies that reduce telogen effluvium during tirzepatide-driven weight loss. Evidence-based guidance for patients managing hair shedding on Zepbound right now.
Read clinical reviewA clinical deep-dive into OTC and prescription treatments for tirzepatide-induced hair loss, including minoxidil dosing, micronutrient correction, and what to avoid while on Zepbound.
Read clinical reviewA clinical review of the best-evidence supplements for managing hair loss caused by Zepbound (tirzepatide), including ferritin, biotin, zinc, vitamin D, and protein targets backed by trials and guidelines.
Read clinical reviewClinical protocols for adjusting Zepbound dose titration to reduce telogen effluvium, including slower schedules, step-downs, microdosing, and when each approach works.
Read clinical reviewClinical thresholds for discontinuing Zepbound due to hair loss: severity grading, lab triggers, timeline benchmarks, and alternative GLP-1 options.
Read clinical reviewZepbound (tirzepatide) can trigger hair loss through telogen effluvium driven by rapid weight loss, caloric deficit, and micronutrient depletion. Learn the biological mechanisms and what the clinical data shows.
Read clinical reviewClinical explanation of how Zepbound (tirzepatide) triggers telogen effluvium through rapid weight loss, caloric restriction, and micronutrient deficits that disrupt the hair growth cycle.
Read clinical reviewA clinical severity grading rubric for hair loss on Zepbound (tirzepatide), including telogen effluvium mechanisms, monitoring guidance, and evidence-based management strategies.
Read clinical reviewWhen hair loss on Zepbound persists beyond the expected telogen effluvium window, a structured clinical workup can identify treatable causes and guide management.
Read clinical reviewExplore why Zepbound causes hair loss, how to manage telogen effluvium on tirzepatide, and which weight-loss medications carry lower alopecia risk.
Read clinical review